| Date | Title | Description |
| 12.02.2025 | Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26 | Company to Host Conference Call with Live Q&A, February 26, 2025, at 4:30pm ET / 22:30 CET
IRVINE, CA, and HERSTAL, BELGIUM – February 12, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, toda... |
| 12.08.2024 | MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21 | MDxHealth to Present Second Quarter and First Half 2024 Financial Results
and Corporate Update on August 21
Company to Host Conference Call with Live Q&A, August 21, 2024, at 4:30pm ET / 22:30 CET
IRVINE, CA, and HERSTAL, BELGIUM – Augu... |
| 12.08.2024 | MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21 | MDxHealth to Present Second Quarter and First Half 2024 Financial Results
and Corporate Update on August 21
Company to Host Conference Call with Live Q&A, August 21, 2024, at 4:30pm ET / 22:30 CET
IRVINE, CA, and HERSTAL, BELGIUM – Augu... |
| 15.05.2024 | Mdxhealth to Present at Upcoming Investor Conferences | Mdxhealth to Present at Upcoming Investor Conferences
IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 (GlobeNewswire) – Mdxhealth SA (Nasdaq: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity... |
| 12.03.2024 | Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering | - |
| 12.03.2024 | Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering | Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a commercial-stage precision ... |
| 06.03.2024 | Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results | - |
| 23.02.2024 | MMI Revolutionizes Microsurgery with $110 Million Series C Financing | MMI, a trailblazer in microsurgery robotics, secures a record-breaking $110 million in Series C financing to propel its mission of transforming open surgery with cutting-edge robotic technology. Led by Fidelity Management & Research Com... |
| 21.02.2024 | MMI Raises $110 Million in Series C Financing | The funds will support commercialization of the Symani® Surgical System in high-growth markets and continued investment in studies that generate clinical evidence and enable indication expansion. Investments will also accelerate advanced te... |
| 12.02.2024 | Internship Offer – Andera Life Sciences | Andera Life Sciences, part of Andera Partners, is one of the leading Life Sciences venture capital teams in Europe and manages funds investing in therapeutics and medical devices. Through its Biodiscovery 6 fund, the team currently invests ... |
| 27.11.2023 | MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq | COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉE
27 NOVEMBRE 2023, 1:00 EDT / 7:00 CET
MDxHealth annonce la réalisation de l'échange obligatoire d'ADS et le début de la période de transition vers une cotation unique sur le Nasdaq
IRVINE, CA, ... |
| 14.11.2023 | MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference | NEWS RELEASE
November 14, 2023, 4PM ET/ 22:00 CET
MDxHealth to Participate in the 35th Annual Piper Sandler
Healthcare Conference
IRVINE, CA, and HERSTAL, BELGIUM – November 14, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a co... |
| 10.08.2023 | MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23 | NEWS RELEASE
10 AUGUST 2023, 4PM ET / 22:00 CET
MDxHealth to Present Q2 and Half Year 2023 Financial Results
and Corporate Update on August 23
Company to Host Conference Call with Live Q&A, August 23, 2023 at 4:30pm ET/ 22:30 CET
IRVINE... |
| 09.08.2023 | Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test | NEWS RELEASE
9 AUGUST 2023, 4PM ET / 22:00 CET
Cigna Expands Commercial and Medicare Advantage
Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test
Expansion of coverage with Cigna now includes full menu of Company’s precisio... |
| 19.04.2023 | Foundational LCD couvre Select mdx pour le cancer de la prostate | /EIN News/ -- COMMUNIQUÉ DE PRESSE - INFORMATION PRIVILÉGIÉE
19 AVRIL 2023, 16h00 EDT/22h00 CET
IRVINE, CA, et HERSTAL, BELGIQUE – 19 avril 2023 – MDxHealth SA (NASDAQ/Euronext : MDXH), une société spécialisée dans le diagnostic de précisio... |
| 19.04.2023 | Foundational LCD Covers Select mdx for Prostate Cancer | /EIN News/ -- NEWS RELEASE – INSIDE INFORMATION
April 19, 2023, 4:00PM EDT / 22:00 CET
IRVINE, CA, and HERSTAL, BELGIUM – April 19, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, received noti... |
| 06.03.2023 | MDxHealth annonce l'exercice de l'option | /EIN News/ -- COMMUNIQUÉ DE PRESSE
INFORMATION RÉGLEMENTÉE
6 MARS 2023, 15h30 EDT/23h30 CET
IRVINE, CA, et HERSTAL, BELGIQUE – 6 mars 2023 – MDxHealth SA (NASDAQ/Euronext : MDXH) (“mdxhealth” ou la “Société“), une société spécialisée dans l... |
| 28.02.2023 | MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference | /EIN News/ -- NEWS RELEASE
FEBRUARY 28, 2023, 4:30 pm ET/ 22:30 CET
IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced ... |
| 13.02.2023 | MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test | /EIN News/ -- NEWS RELEASE
13 FEBRUARY 2023, 4:00PM ET / 22:00 CET
UnitedHealthcare singles out mdxheath’s GPS test as its only commercially-covered test to risk stratify men newly diagnosed with localized prostate cancer
IRVINE, CA, and HE... |
| 03.02.2023 | MDxHealth annonce la détermination du prix de l'offre d'ADSs aux États-Unis | /EIN News/ -- COMMUNIQUÉ DE PRESSE
INFORMATION PRIVILÉGIÉE ET RÉGLEMENTÉE
3 FÉVRIER 2023, 8h00 EDT/14h00 CET
MDxHealth annonce la détermination du prix de l'offre
d'ADSs aux États-Unis
IRVINE, CA, et HERSTAL, BELGIQUE – 3 février 2023 – MDx... |
| 20.01.2023 | MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS Test | MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS Test
MDxHealth SA, a commercial-stage precision diagnostics company, provided supplemental information related to its acquisition of the Oncotyp... |
| 09.01.2023 | MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance | /EIN News/ -- NEWS RELEASE – INSIDE AND REGULATED INFORMATION
9 JANUARY 2023, 4PM ET / 22:00 CET
MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance
IRVINE, CA, and HERSTAL, BELGIUM – January 9, 2023 – MDxHealth ... |
| 09.01.2023 | MDxHealth annonce ses recettes préliminaires pour 2022 et réaffirme ses prévisions de recettes pour 2023 | /EIN News/ -- COMMUNIQUÉ DE PRESSE – INFORMATIONS INTERNES ET RÉGLEMENTÉES
9 JANVIER 2023, 16h00 ET/22h00 CET
MDxHealth annonce ses recettes préliminaires pour 2022 et réaffirme ses prévisions de recettes pour 2023
IRVINE, CA, et HERSTAL, B... |
| 27.10.2022 | MDxHealth Reports Q3-2022 Results | NEWS RELEASE - REGULATED INFORMATION
27 OCTOBER 2022, 4:00PM EDT / 22:00 CET
MDxHealth Reports Q3-2022 Results
IRVINE, CA, and HERSTAL, BELGIUM – October 27, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnost... |
| 25.08.2022 | MDxHealth Reports Half Year 2022 Results | NEWS RELEASE - REGULATED INFORMATION
25 AUGUST 2022, 4:00PM EDT, 22:00 CET
MDxHealth Reports Half Year 2022 Results
IRVINE, CA, and HERSTAL, BELGIUM – August 25, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the &quo... |
| 19.08.2022 | Mdxhealth's New Share Capital Amount and New Number of Shares | NEWS RELEASE - REGULATED INFORMATION
August 19, 2022, 4:00 PM EDT / 22:00 CET
Mdxhealth's New Share Capital Amount and New Number of Shares
IRVINE, CA, and HERSTAL, BELGIUM – August 19, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdx... |
| 08.08.2022 | Digital health news, funding roundup in the prior week; August 8, 2022 | Monkeypox declares a public health emergency; Cera Care raises €310M; Optum partners with Sanofi
Top Health News
Medline, a manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthca... |
| 02.08.2022 | Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results | NEWS RELEASE – INSIDE AND REGULATED INFORMATION
August 2, 2022, 4:00PM EDT / 22:00 CET
Mdxhealth Acquires Oncotype DX® GPS Prostate Cancer Business
from Exact Sciences and Reports Preliminary Half Year 2022 Results Solidifies leadership in ... |
| 19.05.2022 | Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx for Prostate Cancer | NEWS RELEASE - REGULATED INFORMATION
May 19, 2022, 4:00PM EDT / 22:00 CET
Palmetto GBA’s MolDX Issues Foundational LCD Covering the Indication for SelectMDx® for Prostate Cancer
IRVINE, CA, and HERSTAL, BELGIUM – May 19, 2022 – – MDxHealth ... |
| 27.04.2022 | MDxHealth Reports Q1-2022 Results | NEWS RELEASE - REGULATED INFORMATION
27 APRIL 2022, 4:00PM EDT / 22:00 CET
MDxHealth Reports Q1-2022 Results
IRVINE, CA, and HERSTAL, BELGIUM – April 27, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics ... |
| 30.03.2022 | MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference | NEWS RELEASE
March 30, 2022, 4:30 PM EST / 22:30 CET
MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference
IRVINE, CA, and HERSTAL, BELGIUM – March 30, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage pr... |
| 02.03.2022 | MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022 | NEWS RELEASE - REGULATED INFORMATION
2 MARCH 2022, 4:00 PM EST / 22:00 CET
MDxHealth Reports Financial Year 2021 Results
and Provides Outlook and Guidance for 2022
Conference call with Q&A today at 4:30 PM EST / 22:30 CET
IRVINE, CA, an... |
| 17.02.2022 | MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results and Corporate Update on March 2nd | NEWS RELEASE
17 February 2022, 4:00 PM EST / 22:00 CET
MDxHealth to Present Fourth Quarter and Full Year 2021 Financial Results
and Corporate Update on March 2nd
Company to Host Conference Call with Live Q&A, March 2, 2022 at 4:30pm ET/... |
| 09.02.2022 | MDxHealth to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference | NEWS RELEASE
9 FEBRUARY 2022, 4:00 PM EST / 22:00 CET
MDxHealth to Present at BTIG MedTech, Digital Health,
Life Science & Diagnostic Tools Conference
IRVINE, CA, and HERSTAL, BELGIUM – February 9, 2022 – MDxHealth SA (NASDAQ/Euronext: ... |
| 09.01.2022 | MDxHealth : Announces Pricing of Initial Public Offering of ADSs in the United States | MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States
NEWS RELEASE - REGULATED INFORMATION
INSIDE INFORMATION
4 NOVEMBER 2021, 13:00 CET
MDxHealth Announces Pricing of Initial Public Offering of ADSs
in the Uni... |
| 15.12.2021 | MDxHealth : Corporate Presentation 2021 | December 2021
Corporate Presentation
Forward looking statement
This presentation contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such sta... |
| 14.12.2021 | MDxHealth : Shareholder Transparency Declaration - Form 6-K | MDxHealth Shareholder Transparency Declaration
IRVINE, CA, and HERSTAL, BELGIUM - 10 December 2021 - MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage precision diagnost... |
| 23.11.2021 | MDxHealth Shareholder Transparency Declarations | NEWS RELEASE – REGULATED INFORMATION
22 November 2021, 11:00 p.m. CET
MDxHealth Shareholder Transparency Declarations
IRVINE, CA, and HERSTAL, BELGIUM – 22 November 2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the "Company... |
| 04.11.2021 | MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States | NEWS RELEASE - REGULATED INFORMATION
INSIDE INFORMATION
4 NOVEMBER 2021, 13:00 CET
MDxHealth Announces Pricing of Initial Public Offering of ADSs
in the United States
IRVINE, CA, and HERSTAL, BELGIUM – November 4, 2021 – MDxHealth SA (Nasda... |
| 28.10.2021 | MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs in the United States | NEWS RELEASE - REGULATED INFORMATION
INSIDE INFORMATION
28 OCTOBER 2021, 07:00 CEST
MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs
in the United States
IRVINE, CA, and HERSTAL, BELGIUM – October 28, 2021 – MDxHealth ... |
| 27.10.2021 | Board Report in relation to the capital increase of 8 November 2021 (ENG) | English translation - For information purposes only
MDXHEALTH
Limited Liability Company
CAP Business Center
Zone Industrielle des Hauts-Sarts
Rue d'Abhooz 31
4040 Herstal
Belgium
Registered with the Register of Legal Persons
VAT BE 0479.292... |
| 21.10.2021 | MDxHealth Provides Q3-2021 Business Update | NEWS RELEASE - REGULATED INFORMATION
21 OCTOBER 2021, 07:00 A.M. CET
MDxHealth Provides Q3-2021 Business Update
IRVINE, CA, and HERSTAL, BELGIUM – October 21, 2021 – MDxHealth SA (Euronext: MDXH.BR) (“MDxHealth” or the “Company”), a commerc... |
| 26.08.2021 | MDxHealth Reports Half Year 2021 Results | NEWS RELEASE - REGULATED INFORMATION
26 AUGUST 2021, 18:00 CET
MDxHealth Reports Half Year 2021 Results
Conference call with Q&A today at 19:00 CET / 1PM US ET, details provided below
IRVINE, CA, and HERSTAL, BELGIUM – August 26, 2021 –... |
| 22.02.2021 | MDxHealth : Successfully Completes a EUR 25.0 Million (USD 30.4 Million) (1) Capital Increase | IRVINE - MDxHealth SA (Euronext Brussels: MDXH) (the 'Company' or 'MDxHealth'), a commercial-stage innovative molecular diagnostics company, announces the successful pricing of its capital increase with the offering of new ordinary shares.
... |
| 22.02.2021 | MDXHEALTH SA
MDxHealth : Successfully Completes a EUR 25.0 Million (USD 30.4 Million) (1) Capital Increase | IRVINE - MDxHealth SA (Euronext Brussels: MDXH) (the 'Company' or 'MDxHealth'), a commercial-stage innovative molecular diagnostics company, announces the successful pricing of its capital increase with the offering of new ordinary shares.
... |
| 22.01.2021 | MDxHealth : Successfully Completes a EUR 25.0 Million (USD 30.4 Million)(1) Capital Increase | THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW
NEWS RELEASE – REGULAT... |
| 22.01.2021 | MDxHealth : Successfully Completes a EUR 25.0 Million (1) Capital Increase | IRVINE - MDxHealth SA (Euronext Brussels: MDXH) (the 'Company' or 'MDxHealth'), a commercial-stage innovative molecular diagnostics company, announces the successful pricing of its capital increase with the offering of new ordinary shares.
... |
| 22.01.2021 | MDXHEALTH SA
MDxHealth : Successfully Completes a EUR 25.0 Million (1) Capital Increase | IRVINE - MDxHealth SA (Euronext Brussels: MDXH) (the 'Company' or 'MDxHealth'), a commercial-stage innovative molecular diagnostics company, announces the successful pricing of its capital increase with the offering of new ordinary shares.
... |
| 22.01.2021 | MDXHEALTH SA
MDxHealth : Successfully Completes a EUR 25.0 Million (USD 30.4 Million)(1) Capital Increase | THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW
NEWS RELEASE – REGULAT... |
| 11.11.2020 | SA Health scores $200m to complete ehealth records system rollout | SA Health has scored just under $200 million to finish the rollout of the state’s long-delayed Allscripts Sunrise electronic medical record (EMR) and patient administration system (PAS).
Budget papers handed down on Tuesday reveal the gover... |
| 30.09.2020 | MDXHEALTH SA
2020 Interim Report: English I French | 2020 INTERIM REPORT
TABLE OF CONTENTS I. INTERIM MANAGEMENT REPORT ............................................................................... 2
II. INTERIM CONDENSED UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS MDxHealth SA ............... |
| 05.10.2017 | MDxHealth opens new laboratory in The Netherlands | MDxHealth SA (Euronext: MDXH.BR) today announced the opening of its new service and research laboratory at the Novio Tech Campus in Nijmegen, the Netherlands.
MDxHealth has leased 700 square meters of prime mixed-use facilities at the Novi... |
| 15.09.2015 | MDxHealth buys liquid biopsy prostate cancer test for $8.8M | About 1.3 million biopsies are conducted each year to diagnose prostate cancer – but only about 240,000 men have the cancer, indicating that the majority of these tests are excessive. The test aims to reduce the number of unnecessary biopsi... |
| 03.05.2011 | Personalized medicine firm MDxHealth gets $1.1M for cancer diagnostics R&D | MDxHealth CEO Jan Groen said in a statement that the grant provides both companies with the resources to further investigate the biological indicators and patterns seen in bladder cancer. Scientists will study patient samples collected from... |
| 03.05.2011 | MDxHealth wins $1.1 million European grant for cancer research | Funding roundup | Personalized medicine firm MDxHealth SA (BSE:MDXH.BR) and its research partner NovioGendix B.V. won a $1.1 million grant to support the research and development of a new bladder cancer diagnostic.
The funding came from Eurotrans-Bio, a Euro... |
| - | MDxHealth buys liquid biopsy prostate cancer test for $8.8M | Prostate cancer diagnostics company MDxHealth announced it’ll acquire Netherlands-based liquid biopsy testmaker NovioGendix for $8.8 million.
NovioGendix has developed a prostate cancer liquid biopsy test, for which it holds a CE Mark. The ... |
| - | Personalized medicine firm MDxHealth gets $1.1M for cancer diagnostics R&D | Molecular diagnostics company MDxHealth and partner NovioGendix have been awarded a $1.1 million grant that will be applied toward research and development of a new bladder cancer diagnostic.
Belgium-based MDxHealth (BRU:MDXH), which has it... |
